About: Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 02 October 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu n'ochobre de 2020 (ast) scientific article published on 02 October 2020 (en) наукова стаття, опублікована 2 жовтня 2020 (uk)
publication date	wds:Q100428147-80EB3126-06ED-43B1-982B-276DD89B4639
publication date	2020-10-02 00:00:00Z (xsd:dateTime)
cites work	wds:Q100428147-0ECE6778-860E-4183-ABC0-3C7E4C5AC556 wds:Q100428147-128E5637-8301-4CC4-B63A-A17189F5DA66 wds:Q100428147-1D46F004-DF41-432C-ACC0-246297B77DB6 wds:Q100428147-1E9878A1-B961-437E-88B8-165F21A53FF3 wds:Q100428147-1FF3F332-4E15-49D2-8E7E-64B3839BD9EF wds:Q100428147-21EDA784-3842-4D17-B69D-4C4B0444E8EA wds:Q100428147-23B85B0C-C280-4184-8716-3EA7F6BCE49E wds:Q100428147-369BF3DA-5F70-42C7-A0F0-22D587660FB4 wds:Q100428147-36CCB806-0487-4AA7-9098-84022F372F06 wds:Q100428147-37776151-E547-4115-8513-95B99B128795 wds:Q100428147-4CC8FF1E-5B13-43FC-B411-59D941150F22 wds:Q100428147-57892F10-93B4-4C28-910D-12307FF35FC3 wds:Q100428147-5D4C89BF-1228-407D-A707-1FF47E0DB496 wds:Q100428147-5D590896-FEC2-4930-AC51-3278852C65AD wds:Q100428147-663ACCAD-7CD2-4060-9D43-7CDDA7CA2A10 wds:Q100428147-6A16FA31-AD8C-474B-9ECE-0B87758EA66F wds:Q100428147-6CF2785A-F7F5-46AF-BD20-BEB52AECDC7B wds:Q100428147-71CF16DC-B668-43ED-9100-75AA7AE1E791 wds:Q100428147-73B57868-7F02-40F7-B997-2783B02DFD81 wds:Q100428147-776F3EC0-1C78-4D1F-8985-A78418A59F64 wds:Q100428147-7A1EB45E-5772-421B-B311-D0F0420827B3 wds:Q100428147-8061A1A1-2987-40B7-9046-75AC3A1AE8F8 wds:Q100428147-80CCBCE5-160F-4001-9322-608FAAFF6C5D wds:Q100428147-8C5F2CB5-FFC6-49FC-8DBE-6BCEC0DE1B50 wds:Q100428147-A0C89518-B060-4115-93A1-977F7C656ED2 wds:Q100428147-AF07DB7F-5874-4DA8-87E1-4A6B6EB7F1E5 wds:Q100428147-B7C2A343-AC48-4CF8-82DE-2B948B445F9B wds:Q100428147-BAC0804E-F65C-48F4-B377-C57C6D9D38ED wds:Q100428147-C9C7BB42-E994-40BD-A1A4-92C8E70F003D wds:Q100428147-CF044F4A-5144-494E-8C8E-9C9B47E0E06E wds:Q100428147-DFE80E6E-EFCD-4778-87E1-1707E6E70F4D wds:Q100428147-F3171AEC-FCAB-471D-846D-B6E50094C2DD wds:Q100428147-F42E7A43-FCE9-4C87-8D29-B543F006AC8C
cites work	Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials Nonparametric Estimation from Incomplete Observations High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation Defining the intensity of conditioning regimens: working definitions Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease. High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis. Limits of HLA mismatching in unrelated hematopoietic cell transplantation Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in O Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP-EBMT analysis on patients with AML in remission. Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working party Impact of Human Leukocyte Antigen Allele Mismatch in Unrelated Bone Marrow Transplantation with Reduced-Intensity Conditioning Regimen. High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities. Relative Impact of HLA Matching and Non-HLA Donor Characteristics on Outcomes of Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience
author name string	wds:Q100428147-00953BD5-C6D1-4D4B-875A-E0A82665159C wds:Q100428147-07C3A105-955E-4F19-9AD7-43FA85F52E1D wds:Q100428147-1227FA4C-47BE-44FE-BF8E-AB23AE822A7C wds:Q100428147-4F4560FC-7A2E-47B4-AFEF-80CF29DBB8DF wds:Q100428147-79987F30-7189-4DC4-B2E6-E34D063461D4 wds:Q100428147-9CE2B397-F565-4D03-BAC1-DE2E1646766A wds:Q100428147-A2AF3E20-EBAD-4653-8027-CE93BF71479A wds:Q100428147-B49F279C-EF06-4DE4-9373-A73D88079AF3 wds:Q100428147-E46C2ADC-795E-4D30-A00F-383EA34C5CAB wds:Q100428147-F8D3E666-7626-4D7B-AF7C-F00BAE2683A3
author name string	M Gramatzki J Maertens A Ganser M Mohty B Savani J Loke P Jindra J Cornelissen B Afansayev K Boriskina
rdfs:label	Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT (dv) Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT (en) Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT (nl)
skos:prefLabel	Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT (dv) Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT (en) Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT (nl)
name	Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT (dv)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software